The diagnosis of primary hyperoxaluria in young children is hampered by the lack of a reliable reference range for urinary oxalate excretion, especially in infants. We present data on urinary oxalate and glycolate excretion in 137 normal children, on the plasma oxalate concentration in 33 normal children and 53 with chronic renal failure, and on amniotic fluid oxalate concentration in 63 uncomplicated pregnancies. The urinary oxalate:creatinine molar ratios were log normally distributed: mean (range) values were <1 year 0-061 (0-015-0-26), 1-5 years 0-036 (0-011-0-12), 5-12 years 0-030 (0-0059-0.15), and >12 years 0-013 (0-0021-0-083). Geometric mean (range) plasma oxalate concentration in the normal children was 1-53 (0.78-3.02) tmol/l and was independent of age. Without reliable reference ranges the interpretation of urinary oxalate concentrations in young children has been uncertain. There is also some doubt about the appropriate correction of oxalate excretion for body size, and in any case the collection of accurately timed urine specimens from young children is notoriously difficult. In some cases a urine sample is unobtainable because of anuric renal failure: in these circumstances the association between the plasma concentrations of oxalate and creatinine has been used to support the diagnosis of primary hyperoxaluria, but again reference ranges are lacking. Finally, we considered the possibility of prenatal diagnosis of the disorder from amniotic fluid oxalate concentration, but good normal data were not available.
Primary hyperoxaluria type 1 is an inborn error of glyoxalate metabolism characterised by excessive production and urinary excretion of oxalate and glycolate.' Two thirds of the cases present before the age of 5 years with calcium oxalate urolithiasis, and the disease usually runs a progressive course leading to end stage renal failure with systemic oxalosis before adulthood. It is important to diagnose the condition at an early stage so that therapeutic measures can be implemented to reduce the severity of the disease by modifying the risk factors associated with the deposition of calcium oxalate in the urinary tract and in the tissues.
There is, however, a paucity of information in the literature on the urinary excretion rates and plasma concentrations of oxalate and glycolate in young Oxalate concentration was measured enzymatically with immobilised oxalate oxidase,4 glycolate concentration with glycolate oxidase,6 and creatinine by Autoanalyser II using a modified Jaffe alkaline picrate reaction. For plasma and amniotic fluids, ultrafiltrates were prepared for analysis using Amicon Centriflo ultrafiltration membrane cones with molecular weight cut off of 25 000 daltons.
Some of the data were log normally distributed: means, ranges, and correlations were therefore calculated on log transformed results. Surface area was calculated from the formula of Dubois and Dubois.7 UCr) decreased with age (r=-0-50, p<0-0001) (fig 1) . The regression equation was: log (UOx:UCr)=-1-27-0-0425xage (years) Mean and ranges calculated on log transformed data are given in the table. UOx:UCr was significantly higher in infants than in older children (p<0-001). In the 92 children for whom height and weight were known, log (UOx:UCr) correlated similarly with age (r=-0 50), weight (r= -0-50), and surface area (r=-0-48), better than with height (r= -040), but the correlation coefficients were not significantly different from each other.
( PCr, which were both log normally distributed (r=0-93, p<0-0001) (fig 4) . The regression equation was: log POx=-1-39+0-94xlog PCr This association gives POx=1-6 ,umol/l when PCr=50 Fmol/l, and POx= 14-4 ,umol/l when PCr=500 ,mol/l. The mean (SD) POx:PCr ratio was 0-033 (0-013), was independent of age, and never exceeded 0-07. 
